K1 Flashcards
Name six changes/hallmarks which will transform normal cells into cancer cells. List therapeutic targets for three of these hallmarks and justify why you would want to activate or inhibit these targets to reduce the onset of cancer.
A: Activation of invasion and metastasis
R: Resisting cell death –> Pro-apoptotic BH3 mimetics, antagonize Bcl2 famility proteins, induces apoptosis
I: Inducing angiogenesis –> VEGF inhibitors, inhibits growth of new blood vessels
S: Sustaining proliferative growth
E: Evading growth supressors –> CDK inhibitors, to inhibit the cell cycle
E: Enabling replicative immortality
What is angiogenesis and why does a tumor need this to thrive?
The forming of new blood vessles, as tumors need that for nutirents to survive and proliferate
Which cell types are present in the tumor microenvironment of cancers and indicate for
two how they regulate tumor growth.
Cancer stem cells and non-cancer cells.
Cancer stem cells have the ability to self-renewal so they can give rise to all heterogenous lineages of the primary tumor. Can maintain the tumor.
Fibroblasts can come in contact with other cancer cells to induce growth and form another tumor. (collagen)
Name 2 of the 6 original hallmarks and explain how they cause cells to become
cancerous?
Inducing angiogenesis is the growth of blood vessels to provide the tumor with nutrients like glucose. Because of this, the tumor can develop.
Resisting cell death by preventing apoptosis by back-ups
What does the term ‘’self-sufficiency’’ in growth signals mean in cells and describe two
manners in which this can take place?
Preventing tumor formation by blocking the gain of function
Describe the Warburg effect.
Cancer cells preferentially metabolize glucose by glycolysis, to produce lactate despite the present of oxygen, because they need the amino acids to produce new cells from lactate
Does a GPCR function as GEF or GAP? Explain why.
GPCRs function as a GEF as it activates certain proteins.
An inactive GPCR is activated by binding to a ligand. The result is a G-protein with two
activated components. Explain how this is realized.
GPCR goes through a conformational change and activates a G-protein. Then GPCR induces the a-subunit of the G-protein to release GDP and that gets replaced by GTP. This causes conformation change activation in the Ga-subunit which releases the G-protein from the receptor and triggers dissociation of the Ga-subunit from the Gby-pair. They will then interact with its targets as they are activated.
Explain how GPCR signaling activates protein kinase C and mobilizes calcium.
A ligand binds to the GPCR so it becomes active and activates the G-protein which activates phospholipase C-b. This induces IP3 to let go of PI(4,5)P2 and goes to the Calcium channel. This gets phosphorylated and calcium is released into the cytoplasm. The calcium then binds to protein kinase C to activate it.
Explain how GPCR signaling is involved in the production of cAMP and activation of transcription factor CREB.
A ligand binds to the GPCR which activates the G-protein and activates adenyl cyclase protein. cAMP is produced by taking up ATP and activating Pka and is transferred to the nucleus. Pka then induces phosphorylation of CREB to activate it and forms a complex with CBP, this complex then binds to CRE and activates the target gene to induce gene transcription.
How is a G-protein activated?
By GTP/ binding of GPCR bound to ligand
is calcium release always maximal in GPCR signaling?
It is mediated by IP3 to the calcium induced-calcium release/CTCR -> feedback loop
Describe the three modes of adaptation in the desensitization of GPCR?
Sequestration by internalizing the signal-receptor and then emptying the receptor before bringing it back to the membrane
Down-regulation by internalizing and destroying the signal-receptor by lysosomes
Altering the receptor so it can no longer interact with the G-protein
How does the arrestin protein contribute to the desensitization process of GPCR?
GPCR is phosphorylated by GRK and binds to the arrestin protein. This protein then prevents the activated receptor from interacting with G-proteins and helps couple the receptor to the clathrin-dependent endocytosis machinery.
What is the difference between the homologous and heterologous pathways in relation to the desensitization of GPCR?
Homologous = refers to the loss of response to agonists that act on a particular GPCR
Heterologous = a more general effect where simultaneous loss of the agonist on multiple GPCRs, even in absence of occupancy
What is the outcome of the desensitization of GPCR?
Desensitization of GPCR allows the G-protein to not be able to bind to GPCR, so there is no signal. Because the pathway is less sensitive to the hormone, thus reduced signaling
How do receptor protein kinases promote RAS activity?
RTKs indirectly bind to Ras-GEF (SOS) which then stimulates the dissociation of GDP from Ras and its uptake of GTP which activates Ras.
How does signaling through PI 3-kinase promotes cell survival?
Pi 3-kinase becomes activated through RTK. The signaling of PI 3-kinase causes phosphorylation and activation of Akt by PDK1 and mTor, which then phosphorylates Bad. Bad will become inactivated and will in turn activate the apoptosis-inhibitory protein which stimulates cell survival by inhibiting apoptosis.
How is the EGF receptor kinase activated?
The receptor is activated by binding of EGF, this results in a conformational change and you get dimerization. One acts as an activator and the other as a receiver. The activater pushes against the receiver which causes activation of conformational change in the receiver and will phosphorylate multiple tyrosines in the C-terminal tail of the receptors.
Name three important modular binding domains involved in RTK signaling pathways. Specify which domains they bind to.
SH2/PTB: can recognize phosphorylated tyrosine residues
SH3: can recognize scaffold proteins and binds to the proline-rich region
PH: Pleckstrin homology domain, this recognizes PIP3 which are important proteins on the plasma membrane
How does dimerization cause activation of RTKs? How is this different from GPCRs?
Because RTKs can activate each other as they have the same tyrosine kinase domain. When they form a dimer, a ligand will bind to these RTKs whereafter they will phosphorylate each other (auto-phosphorylation) and thus will activate the kinase domains.
How does activation of the EGF receptor vary from the general RTK activation by other external ligands?
For EGF you need one activator and receiver for it to become activated and phosphorylate the tyrosines.
In RTK they can autophosphorylate and don’t need other monomers.